On Thursday, Roche and Qualcomm Incorporated announced that Qualcomm’s subsidiary, Qualcomm Life, Inc., and Roche, a point-of-care diagnostics company, have connected for what promises to be an innovative partnership.
According to details shared with mHealthWatch this morning, the companies are collaborating to improve remote monitoring and management of chronic disease patients.
Together, the companies aim to advance chronic care management using connected therapy to further improve therapy quality, increase convenience and drive patient engagement in managing their health.
Roche will use Qualcomm Life’s 2net platform to capture data from a patient’s medical devices, beginning with anticoagulation meters, and transmit it to Roche’s cloud-based back-end services.
“As health care systems and providers are facing continual pressure to deliver an improved quality of care at a lower cost, patient satisfaction is becoming more important than ever,” a news release heralding the partnership explains. “Connected chronic care management and remote management solutions can enhance patient care, enabling providers to asynchronously communicate with their patients in a high-tech, high-touch model minimizing risk of errors in result reporting. While many remote patient monitoring and management solutions today require patients to communicate results to their healthcare professionals in manual, time-consuming and non-digitized channels, Qualcomm Life and Roche are working together to deliver an improved process for sharing health information between health care providers and their patients.”